This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory regulatory filing

DBV Technologies files share count

Analysis based on 10 articles · First reported Apr 02, 2026 · Last updated Jun 03, 2026

Sentiment
0
Attention
1
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This event provides routine transparency to the market regarding DBV Technologies' share structure. It has minimal direct market impact as it is a standard regulatory disclosure, but it ensures investors have up-to-date information on the company's outstanding shares and voting rights.

Biotechnology

DBV Technologies has issued regulatory filings detailing its total number of voting rights and shares as of March 31, 2026, and May 31, 2026. These filings are in accordance with Article 223-16 of the General Regulations of the France — Autorité des marchés financiers and are relevant to the NYSE Euronext Paris market where DBV Technologies shares are traded. As of March 31, 2026, the company reported 296,042,447 total shares and gross voting rights, with 295,914,379 net voting rights. As of May 31, 2026, the company reported 296,061,497 total shares and gross voting rights, with 295,906,088 net voting rights.

stock
DBV Technologies is the company issuing the regulatory filing regarding its total number of shares and voting rights.
Importance 100.0 Sentiment 0.0
govactor
The France — Autorité des marchés financiers is the regulatory body whose general regulations (Article 223-16) mandate this disclosure.
Importance 40.0 Sentiment 0.0
exch
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.